About us

Our mission is to support health care professionals,
to bring every pregnancy to happy end.

Nestmedic is a privately owned telemedicine company headquartered in the heart of Europe – Wroclaw, Poland.

Our story started 6 years ago, when a personal tragedy inspired our CEO (Patrycja Wizińska-Socha, PhD) to design and introduce a patient friendly, clinical grade, mobile CTG. The company was officially established in 2014, after the first rounds of fund- raising. The product and platform were ready in 2016 and market launch will start at the end of 2016. After the model is qualified in the EU and after the necessary clearances are secured, Nestmedic is planning its launch in the U.S.

Nestmedic’s CEO, Patrycja Wizińska-Socha, was awarded the title of „Innovator of the Year 2016” by MIT Technology Review. Global telecoms technology accelerator Orange Fab awarded Nestmedic a distinction in Poland. Nestmedic has also received a medicine technology award – a distinction for “the most innovative product at the fair” by the organizer of the International Healthcare Exhibition held in Warsaw (WIHE).

Our team consists of experts in R&D, design, engineering, software, medicine, finance and marketing.

Board and the team

Patrycja Wizińska–Socha, MD PhD

CEO

She is a co-founder and President of the Management Board of Nestmedic S.A. Referred to only as an expert in the areas she deals with. Her professional life is also her passion, which is why she easily absorbs new information and practical skills, which ensures her intensive development. She is full of enthusiasm for the tasks she carries out and for the people with whom she works. She likes to challenge herself. She is a pharmaceutical biotechnologist by education, a graduate of the Wrocław University of Technology. She received her PhD from the University of Medical Sciences in Wrocław which as she explains appealed more to her heart than to her mind. She comes from Wałbrzych, a city that was and is amazing, mysterious and inspiring for her (and it’s not just about the fever of gold trains).

Konrad Kowalczuk

Member of the Board, Director of Strategy and Development

He is responsible for setting development directions, achieving strategic goals of the Company and sale. He has extensive expertise and experience in business and organization management. He built it consistently over the years, from the position of a financial analyst to a finance director and a board member. He started his professional career at the Polish-American Mortgage Bank Inc. He continued at KP Consortium, Raiffeisen Private Equity Management, Vivigo Consulting, European Center of Entrepreneurship, Arcus S.A. and the BRASTER telemedical company. A graduate of the Warsaw School of Economics. Privately, he is passionate about snowboarding, crossfit, fishing and westerns.

Anna Skotny, MD PhD

General Director

Co-founder of the company. She is responsible for the processes crucial for the Pregnabit® brand: design, execution and preparation for implementation on the market. She supervises the quality management process in accordance with the international standard for medical devices EN ISO 13485 and cares to take full use of its advantages. She is passionately involved in research on the development of technological solutions for pregnant women. Her aim is to ensure that all tests, not only clinical but also post-marketing, are carried out to the highest standards: always in accordance with test protocols, ICH / GCP regulations and FDA regulations. She tries to make the Pregnabit® system give a sense of security and comfort, both from the point of view of the healthcare worker and the patient. She claims that the highest value is the trust that the users place in the product.

Jolanta Bylica

Communication Director

She is responsible for external communication, both in Poland and on foreign markets. She builds relationships with key recipients for the brand and company – medical staff, patients and investors. She manages PR and marketing activities. She has extensive experience in building and managing communication and teams. For over a decade she was responsible for communication of key Procter & Gamble brands for the Polish and European markets. She also worked for Phoenix Biomedical in Canada, where she was responsible for PR activities and where she managed quality systems. For years, she worked with the editorials of the parenting press and television channels for which she created content. She is a psychologist and a molecular biologist by profession. She studied at the University of Lodz, University of Toronto and the University of Social Sciences and Humanities. Her great pride is her family – husband and three children. She loves traveling, meeting friends, the smell of coffee, the sounds of classical music and a good book.

Sławomir Bartoszcze

Director of International Expansion

In our team he is responsible for the development on foreign markets. He has many years of experience in building business and sales on international markets, including the health care sector. A real enthusiast in action, a leader in project and organization management. He gained and strengthened his professional expertise at CompuGroup Medical Polska, GlaxoSmithKline and Pliva Kraków. An economist and marketer by education. He holds the title of Executive Master of Business and Administration (EMBA) from the Business School of Warsaw University of Technology. In addition, he graduated from such universities as the University of Warsaw, Universidade Portucalense Infante Dom Henrique and the Lublin University of Technology. Privately, a lover of active forms of leisure and good music.

Maciej Stachowiak

Director for Technology and Development

He is responsible for the product’s technological development as well as the market monitoring and planning. In his view, all Nestmedic’s activities must always be patient-oriented. He is an entrepreneur, an investor as well as an experienced team leader. He has been managing businesses and projects in the sectors of medicine, biotechnology and pharmacy for more than 15 years. He is a software engineer by profession. A fan of Elon Musk, Tesla and Space X. He loves diving, American football and car racing.

Robert Woytoń, MD PhD

Medical Director

He has been working on developing the Pregnabit® brand from the very beginning. He is a physician specializing in obstetrics and gynecology. He works in the II Department and Clinic of Gynecology and Obstetrics at the University Clinical Hospital in Wroclaw. He is the author of numerous scientific papers, lectures, scientific presentations in the field of gynecology and obstetrics, including a chapter in a textbook for doctors and students. He studied and practiced in Wrocław and Ruhr-Universität Bochum in Germany. He is particularly involved in prenatal diagnostics and endoscopic gynecological treatment. He strongly believes that mobile technologies provide excellent support for doctors and patients. A fan of extreme sports.

Awards and recognitions

 

Nestmedic’s CEO has been awarded „Innovator Of The Year 2016” by MIT Technology Review.

 

Telecom’s technology accelerator Orange Fab has awarded Nestmedic with distinction in Poland.

 

New Europe 100 — changemakers in Central and Eastern Europe. Res Publica, Google, Visegrad Fund and Financial Times selected 100 innovation leaders from CEE region. Our CEO, Patrycja Wizińska-Socha is on this list.

 

Distinction for „the most innovative product at the fair” by the organizer of International Healthcare Exhibition held in Warsaw (WIHE).

 

Pregnabit among the winners of GO_GLOBAL.PL competition organized by the National Centre for Research and Development. In the recent edition GO_GLOBAL.PL experts evaluated 80 applications for funding. The most innovative companies won, the ones planning to commercialize their solutions in world markets.

Research & Development

NESTMEDIC cooperates with Clinic of Gynecology, Obstetrics and Neonatology of the Academic Hospital in Wroclaw and Universitätsklinikum Carl Gustav Carus Dresden an der Technischen Universität Dresden (University Clinics in Dresden) and the Fraunhofer MOEZ (one of the world’s largest R&Dinstitutes) where works are carried out to support the development of our current teleCTG and telemedicine system.

We are constantly working on incoming improvements (new functionalities) and telemedicine platform. The whole system is constantly improved and adapted to the requirements and expectations of our clients and partners.

At the same time we start working on the second generation device Pregnabit ULTRA II, which will allow for more accurate signal analysis, expanding the functionality of our diagnostic solutions.

PREGNABIT received a document confirming the technological innovation of the proposed solutions issued by the Centre for Innovation and Technology Transfer, University of Medical Sciences, from Wroclaw Medical University.

Innovation on a global scale has been confirmed by the prestigious MIT Technology Review magazine, who gave our CEO, Patricia Wizińskiej – Socha honorary title “Innovator Under 35 in Poland” and the special award “Innovator of the Year 2016”. In the previous year award went to Olga Malinkiewicz (working on perovskites).

The Pregnabit was also chosen the most innovative telemedicine product at the prestigious International Health Exhibition WIHE 2016.